Advertisement
Hoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer Treatment
(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday that it has completed bioanalytical method development under its prior agreement with Altasciences.
The company now plans to further engage Altasciences to perform a key study of mouse blood and plasma analysis from samples collected in Hoth's sponsored scientific research conducted at NC State University.
The blood and plasma samples collected are part of a dose response study in a humanized mouse model.
The upcoming study will use the newly validated bioanalytical method developed at Altasciences to test the amount of HT-KIT from the dose response study and help determine how long HT-KIT remains in the blood stream post dosing.
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews
|
624 ngày trước
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.
RTTNews
|
880 ngày trước
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.
RTTNews
|
980 ngày trước
Malaysia Stock Market Tipped To Open In The Green
The Malaysia stock market has moved lower in back-to-back sessions, slipping almost 10 points or 0.7 percent in that span. The Kuala Lumpur Composite Index now sits just above the 1,525-point plateau although it's due for support on Wednesday.
RTTNews
|
18 phút trước
Win Streak May Continue For Japan Stock Market
The Japan stock market has tracked higher in three straight sessions, accelerating almost 750 points or 2 percent along the way. The Nikkei 225 now sits just shy of the 27,725-point plateau and it may add to its winnings again on Wednesday.
RTTNews
|
33 phút trước
KOSPI Expected To Erase Tuesday's Losses
The South Korea stock market headed south again on Tuesday, one day after ending the two-day slide in which it had given up almost 35 points or 1.4 percent. The KOSPI now rests just above the 2,635-point plateau although it's expected to rebound again on Wednesday.
RTTNews
|
48 phút trước
New Zealand Rate Decision On Tap For Wednesday
The Reserve Bank of New Zealand will wrap up its monetary policy meeting on Wednesday and the announce its decision on interest rates, highlighting a light day for Asia-Pacific economic activity.
The RBNZ is widely expected to trim its Official Cash Rate by 25 basis points, to 3.25 percent from 3.50 percent.
RTTNews
|
1h 48phút trước
U.S. Dollar Strengthens On Trump's Tariff Delay
The U.S. dollar was higher against its major counterparts in the New York session on Tuesday amid easing trade tensions between the U.S. and the European Union.
RTTNews
|
5h 25phút trước
